Pacer Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-485	Closed	-$4.13K	–	2663
2024 Q2	$4.13K	Sell	485 -31	-6%	-$264	﹤0.01%	3628
2024 Q1	$5.27K	Buy	+516	New	+$5.27K	﹤0.01%	3591